CTOs on the Move

H R Medical Supply

www.hrmedical.com

 
H R Medical Supply is a Houston, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.hrmedical.com
  • 1768 W Sam Houston Pkwy N
    Houston, TX USA 77043
  • Phone: 832.358.8001

Executives

Name Title Contact Details

Similar Companies

Nathan Littauer Hospital

Nathan Littauer Hospital and Nursing Home is a full-service, 74 bed acute care hospital with an 84 bed skilled nursing home. Littauer provides the finest in state-of-the-art technology and a caring, dedicated staff of health care professionals. Over the years, the hospital has expanded its services in order offer health care that is comprehensive, accessible, and relevant to the needs of the communities we serve. The Littauer medical staff brings amazing technical expertise and competence to the residents of Fulton County and the surrounding communities. At Nathan Littauer Hospital and Nursing Home, we`re people caring for people.

Fairhaven Crowne

Fairhaven Crowne is a Burlington, VT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

American Healthcare Solutions

American Healthcare Solutions is a Pittsburgh, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

K and S Associates

K and S Associates Inc. is a Nashville, TN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Questcor

We are a biopharmaceutical company focused on the treatment of patients with serious, difficult-to-treat autoimmune and inflammatory disorders. Our efforts are currently focused on the fields of neurology, nephrology and rheumatology, areas of medicine which have significant unmet medical needs. Our main product is H.P Acthar® Gel (repository corticotropin injection), a naturally-derived formulation of adrenocorticotropic hormones used in a variety of disorders having an inflammatory component. We are currently supporting research in a number of rare conditions, where there is significant unmet need for treatment alternatives to standard therapies. We are also actively supporting research efforts to better understand disease processes and therapeutic mechanisms of action in conditions where Acthar might potentially play a role in treatment.